MeSH tree: D02.241.081.193
Researchers at University of Tsukuba have discovered that an immunosuppressive drug affects microglia, the resident immune cells of the brain. In mouse models, the drug reduced levels of guanosine nucleotides, which are essential ...
Feb 5, 2026
0
4
A new machine-learning-based approach to mapping real-time tumor metabolism in brain cancer patients, developed at the University of Michigan, could help doctors discover which treatment strategies are most likely to be effective ...
Jan 12, 2026
0
12
Advancements in HIV/AIDS research, drug development and clinical practice since the 1980s have made it possible for people living with HIV to lead long, productive lives and keep the virus in check at undetectable levels ...
Dec 15, 2025
0
21
For patients with active lupus nephritis, obinutuzumab, a humanized type II anti-CD20 monoclonal antibody plus standard therapy is more efficacious for providing a complete renal response than standard therapy alone, according ...
Feb 26, 2025
0
14
Maintenance immunosuppressive drugs are associated with an increased risk for COVID-19 hospitalization in solid organ transplant recipients, according to a study published online Nov. 7 in JAMA Network Open.
Nov 7, 2023
0
48
At one time, individuals over age 65 typically did not qualify for a kidney transplant. Now, due to advances in medicine and longer life expectancies, these patients represent approximately 15% of all kidney transplants, ...
Oct 18, 2023
0
39
Clinicians have a new standard for graft-versus-host disease (GVHD) prevention after allogeneic hematopoietic stem cell transplantation, according to results from a phase III study published June 22 in the New England Journal ...
Jun 22, 2023
0
58
A new approach to stem cell therapy that uses antibodies instead of traditional immunosuppressant drugs robustly preserves cells in mouse brains and has potential to fast-track trials in humans, a Michigan Medicine study ...
Nov 9, 2022
0
39
New research presented this week at ACR Convergence 2022, the American College of Rheumatology's annual meeting, demonstrated that withholding mycophenolate mofetil for at least 10 days significantly increased antibody response ...
Nov 8, 2022
0
37
A drug normally used to prevent tissue rejection following organ transplants could be repurposed to help treat human metapneumovirus (HMPV) infection in children.
Sep 29, 2022
0
47
